---
title: "Glucose Health (GLUC) stock: news and investor profile"
url: "https://aibio.space/companies/glucose-health/"
publisher: "aibio.space (Biotech Investor Relations News)"
summary: "Glucose Health, Inc. (OTC: GLUC), United States. Listing facts, related biotech companies and news on aibio.space."
---

GLUC Glucose Health, Inc. OTC · United States

# Glucose Health (GLUC) news

Glucose Health, Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker GLUC, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

## Latest Glucose Health news

We have not published a story on Glucose Health yet. When there is news, it will appear here.

## Glucose Health at a glance

- **Ticker**: GLUC

- **Listing**: OTC

- **Country**: United States

- **Cash, Sep 30, 2017**: $16,636

### Related companies

- [Twist Bioscience](https://aibio.space/companies/twist-bioscience/) NASDAQ: TWST
- [Green Planet Bio Engineering Co.](https://aibio.space/companies/green-planet-bio-engineering/) OTC: GPLB
- [QHSLab](https://aibio.space/companies/qhslab/) OTC: USAQ
- [Quanterix](https://aibio.space/companies/quanterix/) NASDAQ: QTRX
- [National Vision Holdings](https://aibio.space/companies/national-vision/) NASDAQ: EYE
- [InMode](https://aibio.space/companies/inmode/) NASDAQ: INMD
- [Global Innovative Platforms](https://aibio.space/companies/global-innovative-platforms/) OTC: GIPL
- [Cytosorbents](https://aibio.space/companies/cytosorbents/) NASDAQ: CTSO

### Also on OTC

- [Abpro Holdings](https://aibio.space/companies/abpro/) ABPO
- [Nascent Biotech](https://aibio.space/companies/nascent-biotech/) NBIO
- [Standard Dental Labs](https://aibio.space/companies/standard-dental-labs/) TUTH
- [Vireo Growth](https://aibio.space/companies/vireo-growth/) VREOF
- [FAMILY OFFICE OF AMERICA, INC.](https://aibio.space/companies/family-office-of-america/) FOFA
- [INTERPACE BIOSCIENCES, INC.](https://aibio.space/companies/interpace-biosciences/) IDXG

## Glucose Health annual financials

| Line | FY2016 | FY2015 |
|---|---|---|
| Research and development |  | [$48](https://www.sec.gov/Archives/edgar/data/1420108/000147793217001354/) |
| Net income (loss) | [-$410,443](https://www.sec.gov/Archives/edgar/data/1420108/000147793217001354/) | [-$266,064](https://www.sec.gov/Archives/edgar/data/1420108/000147793217001354/) |
| Cash from operations | [-$39,263](https://www.sec.gov/Archives/edgar/data/1420108/000147793217001354/) | [-$115,776](https://www.sec.gov/Archives/edgar/data/1420108/000147793217001354/) |
| Cash and equivalents | [$20,542](https://www.sec.gov/Archives/edgar/data/1420108/000147793217005517/) | [$2,055](https://www.sec.gov/Archives/edgar/data/1420108/000147793217005517/) |

Latest balance sheet, Sep 30, 2017 (10-Q): cash and equivalents $16,636.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

## Questions about Glucose Health

What is the ticker symbol of Glucose Health?

Glucose Health, Inc. trades under the ticker GLUC on OTC.

Where is Glucose Health listed?

Glucose Health, Inc. is listed on OTC.

Which country or territory is Glucose Health listed under?

Our directory records Glucose Health, Inc. under United States.

Does aibio.space cover Glucose Health?

aibio.space lists Glucose Health, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Is Glucose Health profitable?

Glucose Health, Inc. reported a net loss of $410,443 for the fiscal year ended Dec 31, 2016, and used $39,263 of cash in operations, per its annual report to the SEC.

How much cash does Glucose Health have?

$16,636 in cash at Sep 30, 2017, per its 10-Q.

## Investor discussion: Glucose Health

Members talk about Glucose Health (GLUC). Reader posts, not aibio.space reporting, and not investment advice.

Rules

1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
2. **Say whether you hold the stock.** Every post states long, short or no position.
3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you.
4. **No buy or sell calls and no price targets.**
5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them.
6. **No personal details and no spam.** No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion).

## Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open OTC:GLUC on TradingView](https://www.tradingview.com/symbols/OTC-GLUC/).

## Listing details

Glucose Health, Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker GLUC, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

- **Company**: Glucose Health, Inc.

- **Ticker**: GLUC

- **Listing**: OTC

- **Country or territory**: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/).

Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/).

Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update)

---
Source page: https://aibio.space/companies/glucose-health/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Glucose Health (GLUC) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/glucose-health/
